These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19540725)

  • 1. Antibiotic resistance among bacterial pathogens in Central Africa: a review of the published literature between 1955 and 2008.
    Vlieghe E; Phoba MF; Tamfun JJ; Jacobs J
    Int J Antimicrob Agents; 2009 Oct; 34(4):295-303. PubMed ID: 19540725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial.
    Morfin-Otero R; Noriega ER; Dowzicky MJ
    Ann Clin Microbiol Antimicrob; 2015 Dec; 14():53. PubMed ID: 26667651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).
    Streit JM; Jones RN; Sader HS; Fritsche TR
    Int J Antimicrob Agents; 2004 Aug; 24(2):111-8. PubMed ID: 15288308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011.
    Kanj SS; Whitelaw A; Dowzicky MJ
    Int J Antimicrob Agents; 2014 Feb; 43(2):170-8. PubMed ID: 24315313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of multidrug-resistant Gram-negative pathogens isolated from ventilator-associated pneumonia in ICU patients.
    Gupta R; Malik A; Rizvi M; Ahmed M; Singh A
    J Glob Antimicrob Resist; 2017 Jun; 9():47-50. PubMed ID: 28288860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.
    Vega S; Dowzicky MJ
    Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):50. PubMed ID: 28701170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trending 7 years of in vitro activity of tigecycline and comparators against Gram-positive and Gram-negative pathogens from the Asia-Pacific region: Tigecycline Evaluation Surveillance Trial (TEST) 2004-2010.
    Hawser SP; Bouchillon SK; Hackel M; Chen M; Kim EC
    Int J Antimicrob Agents; 2012 Jun; 39(6):490-5. PubMed ID: 22534507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftriaxone activity against Gram-positive and Gram-negative pathogens isolated in US clinical microbiology laboratories from 1996 to 2000: results from The Surveillance Network (TSN) Database-USA.
    Karlowsky JA; Jones ME; Mayfield DC; Thornsberry C; Sahm DF
    Int J Antimicrob Agents; 2002 May; 19(5):413-26. PubMed ID: 12007850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriologic profile and antibiogram of blood culture isolates from a children's hospital in Kabul.
    Tariq TM
    J Coll Physicians Surg Pak; 2014 Jun; 24(6):396-399. PubMed ID: 24953929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).
    Nørskov-Lauritsen N; Marchandin H; Dowzicky MJ
    Int J Antimicrob Agents; 2009 Aug; 34(2):121-30. PubMed ID: 19342205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surveillance of antimicrobial resistance of bacteria isolated from bloodstream infections: data of the French National Observatory for Epidemiology of Bacterial Resistance to Antibiotics (ONERBA), 1998-2003].
    Bertrand X; Costa Y; Pina P
    Med Mal Infect; 2005 Jun; 35(6):329-34. PubMed ID: 16039819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICU Pathogens: A Continuous Challenge.
    Hafeez A; Munir T; Najeeb S; Rehman S; Gilani M; Ansari M; Saad N
    J Coll Physicians Surg Pak; 2016 Jul; 26(7):577-80. PubMed ID: 27504548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic resistance surveillance over a 4-year period (2000-2003) in Turkey: results of the MYSTIC Program.
    Korten V; Ulusoy S; Zarakolu P; Mete B;
    Diagn Microbiol Infect Dis; 2007 Dec; 59(4):453-7. PubMed ID: 17888609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern of Polymicrobial Isolates and Antimicrobial Susceptibility from Blood.
    Shabbir S; Jamil S; Hafiz S
    J Coll Physicians Surg Pak; 2016 Jul; 26(7):585-8. PubMed ID: 27504550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fosfomycin: mechanisms and the increasing prevalence of resistance.
    Aghamali M; Sedighi M; Zahedi Bialvaei A; Mohammadzadeh N; Abbasian S; Ghafouri Z; Kouhsari E
    J Med Microbiol; 2019 Jan; 68(1):11-25. PubMed ID: 30431421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative activity of meropenem in US medical centers (2007): initiating the 2nd decade of MYSTIC program surveillance.
    Jones RN; Kirby JT; Rhomberg PR
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):203-13. PubMed ID: 18329835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of β-lactam antimicrobial resistance and epidemiology of major community- and healthcare-associated multidrug-resistant bacteria.
    Tang SS; Apisarnthanarak A; Hsu LY
    Adv Drug Deliv Rev; 2014 Nov; 78():3-13. PubMed ID: 25134490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in the distribution and antimicrobial susceptibility of causative pathogens of device-associated infection in Korean intensive care units from 2006 to 2013: results from the Korean Nosocomial Infections Surveillance System (KONIS).
    Choi JY; Kwak YG; Yoo H; Lee SO; Kim HB; Han SH; Choi HJ; Kim HY; Kim SR; Kim TH; Lee H; Chun HK; Kim JS; Eun BW; Kim DW; Koo HS; Cho EH; Lee K;
    J Hosp Infect; 2016 Apr; 92(4):363-71. PubMed ID: 26876746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility of gram-negative and gram-positive bacteria collected from countries in Eastern Europe: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2004-2010.
    Balode A; Punda-Polić V; Dowzicky MJ
    Int J Antimicrob Agents; 2013 Jun; 41(6):527-35. PubMed ID: 23590898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.